DOCSLIB.ORG

Program Book

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Program Book ACNP 53rd Annual Meeting Final Program December 7-11, 2014 JW Marriott Phoenix Desert Ridge Resort and Spa Phoenix, Arizona President: Peter W. Kalivas, Ph.D. Program Committee Chair: Pat R. Levitt, Ph.D. Program Committee Co-Chair: Bita Moghaddam, Ph.D. This meeting is jointly sponsored by the Vanderbilt University School of Medicine Department of Psychiatry and the American College of Neuropsychopharmacology. ACNP Annual Meeting Book Cover 2014.indd 1 10/24/14 8:36 AM Dear Friends and Colleagues Welcome to the 53rd annual meeting of the American College of Neuropsychopharmacology. It has been a great distinction and pleasure for me to work with your colleagues to help develop this year’s program of events and scientific symposia. The JW Marriott is an outstanding venue that promises more than adequate meeting space and areas to gather in discussion offering a great opportunity to have fun, enjoy your colleagues and experience the latest advances in neuroscience discovery related to neuropsychiatric disease. Thanks to the Program Committee and the committee chair, Pat Levitt, and his co-chair, Bita Moghaddam, we have an exciting program for this year’s meeting that contains innovations to promote scientific exchange and provide opportunity to participate across our membership. For example, the evening Workshops that are built around discussion more than presentation are moved into the daytime program. Thanks to the membership’s effort to create a meeting that provides opportunity across our membership, you will experience scientifically excellent symposia that are by far our most demographically diverse. The ACNP is a unique amalgamation of preclinical, clinical, government, academic and industrial researchers. This is emphasized in the program as we made an effort to mix these branches of our field under an umbrella that encompasses many topics of shared interest, including exploring how the BRAIN Initiative may impact our field and the direction of discovery. Our field has never been more exciting and cutting-edge in terms of new technology with the potential to bring forward completely unexpected avenues for treating neuropsychiatric disorders. Our program embraces these new possibilities. Serving as the President of the ACNP over the last year has been a great honor. However, the excellence and quality of this year’s program and of the ACNP itself is insured by active consultation with ACNP Council, and most importantly, by the extraordinarily dedicated and talented staff that is led by Ronnie Wilkins, Sarah Timm and Laura Hill. Welcome to Arizona! Peter W. Kalivas, Ph.D. President 2014 ACNP Annual Meeting Book Cover 2014.indd 2 10/24/14 8:36 AM ACNP AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY 53rd ANNUAL MEETING GENERAL PROGRAM PHOENIX, ARIZONA JW MARRIOTT PHOENIX DESERT RIDGE RESORT DECEMBER 7-11, 2014 Disclosures for 2014 speakers (mini-panel, panel, study group, and plenary) and poster presenters may be found online at: www.acnp.org (click the Annual Meeting tab). Vanderbilt CME has determined that there is no conflict of interest. ACNP Annual Meeting Book 2014 rev14.indd 1 11/5/14 10:42 AM ACNP 53rd Annual Meeting • Final Program JW Marriott Phoenix Desert Ridge Resort Map RESORT ELEMENTS A. Wildflower Ballroom K. Stonegrill Restaurant B. Meritage Steakhouse L. Stonegrill Bar C. The Clubhouse Green M. Just A Splash D. Pinnacle Peak Conference Rooms N. Twenty6 E. Kinko’s O. Roy’s Hawaiian Fusion Cuisine F. Canyon Villas Gallery P. Family Escape G. Starbucks Q. Fitness Center H. Shops R. Ristorante Tuscany I. Boardrooms S. Hertz Rent A Car J. Desert Conference Suites T. Flower & Herb Garden Note: the numbers 1-5 on the map refer to wings of the resort and correspond to guest room numbers as follows – floor, wing, room. Example: if your room number is 5224, you are on the 5th floor, wing 2, room 24. ii ACNP Annual Meeting Book 2014 rev14.indd 2 11/5/14 10:42 AM ACNP 53rd Annual Meeting • Final Program JW Marriott Phoenix Desert Ridge Resort Meeting Space Diagram iii ACNP Annual Meeting Book 2014 rev14.indd 3 11/5/14 10:42 AM ACNP 53rd Annual Meeting • Final Program Program at a Glance Saturday, December 6, 2014 Monday, December 8, 2014 Monday, December 8, 2014 8:00 AM - 3:00 PM Desert Conference 6:45 AM - 8:00 AM Desert Conference 7:30 PM - 9:00 PM Grand Sonoran ACNP Council Meeting Suites I - II CDI Booster Session Suite IV Early Precursors, Core Salons H - J Features and Intermediate Phenotypes of 7:00 AM - 8:00 AM Grand Sonoran Salon A 8:00 AM - 5:00 PM Wildflower Ballroom B Bipolar Disorder ACNP Membership Committee Meeting ACNP Underrepresented Minority Task Force Breakfast (by invitation) 7:30 PM - 9:00 PM Grand Canyon 2:00 PM - 4:00 PM Desert Conference Using Big Neuroimaging Salons 9 - 11 Neuropsychopharmacology & Suite III 7:00 AM - 8:00 AM President’s Boardroom MD/PhD Trainee Travel Awardee Roundtable Datasets to Understand Neuropsychiatric Neuropsychopharmacology Reviews Disease Across the Lifespan EIC & Deputy Editors Meeting (by invitation) 8:00 AM - 11:30 AM Grand Canyon 3:00 PM - 4:00 PM Desert Conference President’s Plenary: Salons 1 - 8 Tuesday, December 9, 2014 ACNP Advocacy Suite IV “The Brain Initiative: Visualizing, Mapping and Subcommittee Meeting 7:00 AM - 8:00 AM Desert Conference Controlling Brain Function” American Journal of Suite IV 4:00 PM - 5:30 PM Desert Conference 11:30 AM - 1:30 PM Wildflower Ballroom Psychiatry Editorial Board Meeting ACNP Publications Suite V Data Blitz Committee Meeting 7:00 AM - 8:30 AM Grand Sonoran Salon K 1:30 PM - 3:00 PM Grand Canyon ACNP Membership Advisory Task Force 4:00 PM - 5:30 PM President’s Boardroom Distinguished Lecture: Salons 1 - 8 Meeting ACNP Ethics Committee Meeting “Brain-Machine Interfaces: 7:00 AM - 8:30 AM Grand Canyon Past, Present and Future” 6:30 PM - 8:30 PM Grand Saguaro Ballroom ACNP Education and Salons 12-13 ACNP Travel Award Reception Panel Sessions Training Committee Meeting (by invitation) 3:00 PM - 5:30 PM Grand Sonoran 7:30 AM - 8:30 AM Grand Sonoran Salon A Sunday, December 7, 2014 Impact of Common and Rare Salons B - D ACNP Leadership & Institute Directors Meeting Genetic Variants on Brain Phenotypes Study Group Session 7:00 AM - 8:30 AM Desert Conference 3:00 PM - 5:30 PM Grand Sonoran Salon E ACNP Public Information Suite I Rhythm Disruptions and Mood Disorders: 8:30 AM - 11:00 AM Grand Sonoran Salon E Committee Meeting Looking Beyond the SCN Proponents and Opponents of Legalization of Marijuana: Evidence of Benefits and Costs 8:30 AM - 11:30 AM Grand Canyon 3:00 PM - 5:30 PM Grand Sonoran Salon F in Three Areas (Psychosis, Cognition, and 2014 Salons 6 - 8 Drug Repurposing and Emerging Adjunctive Motivation) Neuropsychopharmacology Reviews Plenary Treatments for Schizophrenia 11:30 AM - 1:00 PM Grand Sonoran Salon D 3:00 PM - 5:30 PM Grand Sonoran Salon G Panel Sessions Neuropsychopharmacology (NPP) Editorial Trans-species Models Examining Estradiol 8:30 AM - 11:00 AM Grand Sonoran Board Effects on Emotion and Cognition Across Developmental and Molecular Salons B - D Development 11:30 AM - 1:00 PM Grand Canyon Mechanisms in Frontal Systems in Suicide ACNP Liaison Committee Salons 1 - 2 3:00 PM - 5:30 PM Grand Sonoran 8:30 AM - 11:00 AM Grand Sonoran Salon F Meeting Stress Resilience Molecules Salons H - J Beyond AKT1: Emerging Role of the AKT and Mechanisms 11:30 AM - 1:00 PM President’s Boardroom Signaling Network in Neurodevelopment, ACNP Past President’s Luncheon 3:00 PM - 5:30 PM Grand Canyon Cognition and Developmental Psychiatric Abnormal Calcium Regulation Salons 9 - 11 Disorders 11:30 AM - 1:00 PM Grand Canyon in Bipolar Disorder: Genetics, Cellular 8:30 AM - 11:00 AM Grand Sonoran Salon G ACNP Program Committee Salons 4 - 5 Phenotype, Biomarkers, Molecular Pathways, Psychosis Prodrome: Toward the Validation of Meeting and Novel Therapeutic Targets Biomarkers for Clinical Trials 11:30 AM - 1:00 PM Grand Sonoran Salon A 3:00 PM - 5:30 PM Wildflower Ballroom FNIH Biomarkers Consortium Neuroscience Hypodopaminergia: Does It Have a Role in Drug 8:30 AM - 11:00 AM Grand Sonoran Senior Leadership Meeting Addiction? Genetic and Epigenetic Salons H - J Contributions to Reproductive-related 11:30 AM - 1:00 PM Desert Conference 5:30 PM - 7:30 PM Grand Saguaro Ballroom Mood Disorders NIMH - U19 Program Project- Suite I Poster Session I with Reception Duke - UNC- Pfizer 8:30 AM - 11:00 AM Grand Canyon Mini-Panel Sessions Alcohol Craving: Salons 9 - 11 1:00 PM - 2:30 PM Grand Canyon 7:30 PM - 9:00 PM Grand Sonoran The Gut and Liver in the Brain NIH Institutes Directors’ Session Salons 6 - 8 Latest Development in Salons B - D 8:30 AM - 11:00 AM Wildflower Ballroom Convulsive Therapy for Depression and 2:30 PM - 6:30 PM Grand Canyon Neural Circuitry Contributing to Mood, Schizophrenia: A Revival Story Hot Topics Salons 6 - 8 Impulsivity, and Decision Making in Bipolar 7:30 PM - 9:00 PM Grand Sonoran Salon E and Other Inhibitory Disorders: Studies from 6:30 PM - 7:30 PM Grand Canyon Salon 5 Inhibitory Neuron Development in Imaging and Genetics, to Pharmacology and Women Mentees and Mentors Reception Developmental Psychopathology: Animal Model Organisms 6:30 PM - 7:30 PM Grand Canyon Salon 3 Models of Gabaergic Neuron Genetic 11:30 AM - 1:00 PM Grand Canyon Associate Member Reception Regulation, Responses to Prenatal Stress and Postnatal Parvalbumin Elimination ACNP Women’s Luncheon Salons 7 - 8 7:00 PM - 9:00 PM Ballroom Lawn, 1:30 PM - 3:00 PM Wildflower Ballroom ACNP Opening Reception Wildflower 7:30 PM - 9:00 PM Grand Sonoran
Load more

Recommended publications
  • Dopamine D1 Rather Than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
    Neuropsychopharmacology (2003) 28, 108–118 & 2003 Nature Publishing Group All rights reserved 0893-133X/03 $25.00 www.neuropsychopharmacology.org Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice 1 2 ,2 Rebecca J Ralph-Williams , Virginia Lehmann-Masten and Mark A Geyer* 1 2 Alcohol and Drug Abuse Research Center, Harvard Medical School and McLean Hospital, Belmont, MA, USA; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA Although substantial literature describes the modulation of prepulse inhibition (PPI) by dopamine (DA) in rats, few reports address the effects of dopaminergic manipulations on PPI in mice. We characterized the effects of subtype-specific DA agonists in the PPI paradigm to further delineate the specific influences of each DA receptor subtype on sensorimotor gating in mice. The mixed D1/D2 agonist apomorphine and the preferential D1-family agonists SKF82958 and dihydrexidine significantly disrupted PPI, with differing or no effects on startle. In contrast to findings in rats, the D2/D3 agonist quinpirole reduced startle but had no effect on PPI. Pergolide, which has affinity for D2/D3 and D1-like receptors, reduced both startle and PPI, but only at the higher, nonspecific doses. In addition, the D1-family receptor antagonist SCH23390 blocked the PPI-disruptive effects of apomorphine on PPI, but the D2-family receptor antagonist raclopride failed to alter the disruptive effect of apomorphine. These studies reveal potential species differences in the DA receptor modulation of PPI between rats and mice, where D1-family receptors may play a more prominent and independent role in the modulation of PPI in mice than in rats.
    [Show full text]
  • Abstract Book – Oral Sessions
    Sunday, June 21, 2015 12:00 p.m. - 1:15 p.m. Latin American Psychopharmacology Update: INNOVATIVE TREATMENTS IN PSYCHIATRY INNOVATIVE TREATMENTS IN PSYCHIATRY Flavio Kapczinski, The University of Texas Health Science Center at Houston Overall Abstract In this panel, we will propose innovative treatments in psychiatry and recent literature findings will be summarized. The effective pharmacological treatment of psychiatric diseases and development of new therapeutic entities has been a long-standing challenge. Despite the complexity and heterogeneity of psychiatric disorders, basic and clinical research studies and technological advancements in genomics, biomarkers, and imaging have begun to elucidate the pathophysiology of etiological complexity of psychiatric diseases and to identify efficacious new agents (Tcheremissine et al. 2014). Many psychiatric illnesses are associated with neuronal atrophy, characterized by loss of synaptic connections, increase of inflammatory markers like TNF-α and DAMPS (damage-associate molecular patterns,- cell free (ccf) DNA, heat shock proteins HSP70, HSP90, and HSP60, and cytochrome C), decrease of neurotrophic factors, increase of oxidative stress, mitochondrial dysfunction and apoptosis (Fries et al., 2012; Pfaffenseller et al., 2014). Also, neurocognitive impairment and poor psychosocial functioning has been related to a psychiatric disease. Therefore, trying to discover new therapeutic targets that act in these pathways can help to develop new treatment or improve the treatment of these serious diseases.
    [Show full text]
  • Debbie Sookman Is an Outstanding Contribution to the Science and Clinical Practice Related to the Full Range of Obsessive Com- Pulsive Disorder
    Downloaded by [New York University] at 04:59 12 August 2016 “I strongly recommend this expert clinical guide to the psychological treat- ment of obsessive compulsive disorders. The depth of Dr. Sookman’s clinical experience and her command of the literature are evident in the thorough coverage of assessment procedures, how to optimize the effects of therapy and deal with problems. The numerous case illustrations are well-chosen and clearly described.” —S. Rachman, Emeritus Professor, Institute of Psychiatry, London University, and University of British Columbia. “Specialized Cognitive Behavior Therapy for Obsessive Compulsive Disorder: An Expert Clinician Guidebook by Dr. Debbie Sookman is an outstanding contribution to the science and clinical practice related to the full range of Obsessive Com- pulsive Disorder. This is an excellent book in every way imaginable. Clearly written and organized, Sookman provides a critical and scholarly review of the state of the art on OCD. Every researcher and clinician can benefit from this superb book. The reader benefits from the considerable clinical expe- rience and scholarship that Dr Sookman possesses, while learning specific and powerful tools in helping those who suffer from OCD. Case examples illustrate the importance of conceptualization and the value of empirically supported treatments. I am particularly impressed that Sookman was able to balance such sophistication in her critical and scientific understanding of OCD, while still writing a clear and concise book on the topic. This is a book I will recommend to both beginning clinicians in training and to seasoned researchers and practitioners.” —Robert L. Leahy, Ph.D., Director, American Institute for Cognitive Therapy “Dr.
    [Show full text]
  • Dopamine: a Role in the Pathogenesis and Treatment of Hypertension
    Journal of Human Hypertension (2000) 14, Suppl 1, S47–S50 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh Dopamine: a role in the pathogenesis and treatment of hypertension MB Murphy Department of Pharmacology and Therapeutics, National University of Ireland, Cork, Ireland The catecholamine dopamine (DA), activates two dis- (largely nausea and orthostasis) have precluded wide tinct classes of DA-specific receptors in the cardio- use of D2 agonists. In contrast, the D1 selective agonist vascular system and kidney—each capable of influenc- fenoldopam has been licensed for the parenteral treat- ing systemic blood pressure. D1 receptors on vascular ment of severe hypertension. Apart from inducing sys- smooth muscle cells mediate vasodilation, while on temic vasodilation it induces a diuresis and natriuresis, renal tubular cells they modulate sodium excretion. D2 enhanced renal blood flow, and a small increment in receptors on pre-synaptic nerve terminals influence nor- glomerular filtration rate. Evidence is emerging that adrenaline release and, consequently, heart rate and abnormalities in DA production, or in signal transduc- vascular resistance. Activation of both, by low dose DA tion of the D1 receptor in renal proximal tubules, may lowers blood pressure. While DA also binds to alpha- result in salt retention and high blood pressure in some and beta-adrenoceptors, selective agonists at both DA humans and in several animal models of hypertension. receptor classes have been studied in the treatment of
    [Show full text]
  • Microrna Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms Behind Variable Drug Disposition and Strategy to Develop More Effective Therapy
    1521-009X/44/3/308–319$25.00 http://dx.doi.org/10.1124/dmd.115.067470 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 44:308–319, March 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics Minireview MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy Ai-Ming Yu, Ye Tian, Mei-Juan Tu, Pui Yan Ho, and Joseph L. Jilek Department of Biochemistry & Molecular Medicine, University of California Davis School of Medicine, Sacramento, California Received September 30, 2015; accepted November 12, 2015 Downloaded from ABSTRACT Knowledge of drug absorption, distribution, metabolism, and excre- we review the advances in miRNA pharmacoepigenetics including tion (ADME) or pharmacokinetics properties is essential for drug the mechanistic actions of miRNAs in the modulation of Phase I and development and safe use of medicine. Varied or altered ADME may II drug-metabolizing enzymes, efflux and uptake transporters, and lead to a loss of efficacy or adverse drug effects. Understanding the xenobiotic receptors or transcription factors after briefly introducing causes of variations in drug disposition and response has proven the characteristics of miRNA-mediated posttranscriptional gene dmd.aspetjournals.org critical for the practice of personalized or precision medicine. The regulation. Consequently, miRNAs may have significant influence rise of noncoding microRNA (miRNA) pharmacoepigenetics and on drug disposition and response. Therefore, research on miRNA pharmacoepigenomics has come with accumulating evidence sup- pharmacoepigenetics shall not only improve mechanistic under- porting the role of miRNAs in the modulation of ADME gene standing of variations in pharmacotherapy but also provide novel expression and then drug disposition and response.
    [Show full text]
  • The Opioid Epidemic: Crisis and Solutions
    PA58CH09-Skolnick ARI 18 November 2017 9:40 Annual Review of Pharmacology and Toxicology The Opioid Epidemic: Crisis and Solutions Phil Skolnick Opiant Pharmaceuticals, Santa Monica, California 09401, USA; email: [email protected] Annu. Rev. Pharmacol. Toxicol. 2018. 58:143–59 Keywords First published as a Review in Advance on heroin, overdose, naloxone, vaccines, medication-assisted therapies, pain October 2, 2017 The Annual Review of Pharmacology and Toxicology Abstract by [email protected] on 01/16/18. For personal use only. is online at pharmtox.annualreviews.org The widespread abuse of prescription opioids and a dramatic increase in https://doi.org/10.1146/annurev-pharmtox- the availability of illicit opioids have created what is commonly referred to 010617-052534 as the opioid epidemic. The magnitude of this epidemic is startling: About Copyright c 2018 by Annual Reviews. 4% of the adult US population misuses prescription opioids, and in 2015, Annu. Rev. Pharmacol. Toxicol. 2018.58:143-159. Downloaded from www.annualreviews.org All rights reserved more than 33,000 deaths were attributable to overdose with licit and illicit opioids. Increasing the availability of medication-assisted treatments (such as buprenorphine and naltrexone), the use of abuse-deterrent formulations, and ANNUAL REVIEWS Further the adoption of US Centers for Disease Control and Prevention prescribing Click here to view this article's guidelines all constitute short-term approaches to quell this epidemic. How- online features: • Download figures as PPT slides ever, with more than 125 million Americans suffering from either acute or • Navigate linked references • Download citations chronic pain, the development of effective alternatives to opioids, enabled at • Explore related articles • Search keywords least in part by a fuller understanding of the neurobiological bases of pain, offers the best long-term solution for controlling and ultimately eradicating this epidemic.
    [Show full text]
  • Duke University Hdt What? Index
    DUKE UNIVERSITY HDT WHAT? INDEX DUKE UNIVERSITY DUKE UNIVERSITY 1838 James Thomas Fields was hired by the Boston bookselling firm of William D. Ticknor, which would become Ticknor, Reed & Fields in 1854 and Fields, Osgood & Company in 1868. 1832-1834 Allen & Ticknor 1834-1843 William D. Ticknor 1843-1849 William D. Ticknor & Co. 1849-1854 Ticknor, Reed & Fields 1854-1868 Ticknor and Fields 1868-1871 Fields, Osgood & Co. 1871-1878 James R. Osgood & Co. 1878-1880 Houghton, Osgood, & Co. 1880-1908 Houghton, Mifflin, & Co. 1908-2007 Houghton Mifflin Company 2007-???? Houghton Mifflin Harcourt In Boston, Isaac Knapp printed AMERICAN ANTI-SLAVERY ALMANAC FOR 1838 edited by Nathaniel Southard. He also printed the Reverend Thomas Treadwell Stone’s THE MARTYR OF FREEDOM: A DISCOURSE DELIVERED AT EAST MACHIAS, NOVEMBER 30, AND AT MACHIAS, DECEMBER 7, 1837, John Gabriel Stedman’s NARRATIVE OF JOANNA; AN EMANCIPATED SLAVE, OF SURINAM, Elizabeth Heyrick’s IMMEDIATE, NOT GRADUAL ABOLITION: OR, AN INQUIRY INTO THE SHORTEST, SAFEST, AND MOST EFFECTUAL MEANS OF GETTING RID OF WEST INDIAN SLAVERY, Friend Sarah Moore Grimké’s LETTERS ON THE EQUALITY OF THE SEXES, AND THE CONDITION OF WOMAN: ADDRESSED TO MARY S. PARKER, PRESIDENT OF THE BOSTON FEMALE ANTI-SLAVERY SOCIETY, James Williams’s NARRATIVE OF JAMES WILLIAMS, AN AMERICAN SLAVE, WHO WAS FOR SEVERAL YEARS A DRIVER ON A COTTON PLANTATION IN ALABAMA, and a 3d edition of Phillis Wheatley’s MEMOIR AND POEMS OF PHILLIS WHEATLEY, A NATIVE AFRICAN AND A SLAVE, along with poems published in 1829 and 1837 by the still-enslaved George Moses Horton of North Carolina.
    [Show full text]
  • Abstract Book
    Table of Contents Tuesday, May 25, 2021 ............................................................................................................................................................... 5 T1. Astrocyte-Specific Expression of the Extracellular Matrix Gene HtrA1 Regulates Susceptibility to Stress in a Sex- Specific Manner ....................................................................................................................................................................... 5 T2. Plexin-B2 Regulates Migratory Plasticity of Glioblastoma Cells in a 3D-Printed Micropattern Device ............................. 5 T3. Pathoanatomical Mapping of Differential MAPT Expression and Splicing in Progressive Supranuclear Palsy ............... 5 T4. Behavioral Variability in Response to Chronic Stress and Morphine in BXD and Parental Mouse Lines......................... 6 T5. Thyroid-Stimulating Hormone Receptor Regulates Anxiety .............................................................................................. 6 T6. Drugs That Inhibit Microglial Inflammation Also Ameliorate Aβ1-42 Induced Toxicity in C. Elegans ............................... 7 T7. Phosphodiesterase 1b is an Upstream Regulator of a Key Gene Network in the Nucleus Accumbens Driving Addiction- Like Behaviors ......................................................................................................................................................................... 7 T8. Reduced Gap Effect in Children With FOXP1 Syndrome and Autism Spectrum
    [Show full text]
  • Brain Imaging
    Publications · Brochures Brain Imaging A Technologist’s Guide Produced with the kind Support of Editors Fragoso Costa, Pedro (Oldenburg) Santos, Andrea (Lisbon) Vidovič, Borut (Munich) Contributors Arbizu Lostao, Javier Pagani, Marco Barthel, Henryk Payoux, Pierre Boehm, Torsten Pepe, Giovanna Calapaquí-Terán, Adriana Peștean, Claudiu Delgado-Bolton, Roberto Sabri, Osama Garibotto, Valentina Sočan, Aljaž Grmek, Marko Sousa, Eva Hackett, Elizabeth Testanera, Giorgio Hoffmann, Karl Titus Tiepolt, Solveig Law, Ian van de Giessen, Elsmarieke Lucena, Filipa Vaz, Tânia Morbelli, Silvia Werner, Peter Contents Foreword 4 Introduction 5 Andrea Santos, Pedro Fragoso Costa Chapter 1 Anatomy, Physiology and Pathology 6 Elsmarieke van de Giessen, Silvia Morbelli and Pierre Payoux Chapter 2 Tracers for Brain Imaging 12 Aljaz Socan Chapter 3 SPECT and SPECT/CT in Oncological Brain Imaging (*) 26 Elizabeth C. Hackett Chapter 4 Imaging in Oncological Brain Diseases: PET/CT 33 EANM Giorgio Testanera and Giovanna Pepe Chapter 5 Imaging in Neurological and Vascular Brain Diseases (SPECT and SPECT/CT) 54 Filipa Lucena, Eva Sousa and Tânia F. Vaz Chapter 6 Imaging in Neurological and Vascular Brain Diseases (PET/CT) 72 Ian Law, Valentina Garibotto and Marco Pagani Chapter 7 PET/CT in Radiotherapy Planning of Brain Tumours 92 Roberto Delgado-Bolton, Adriana K. Calapaquí-Terán and Javier Arbizu Chapter 8 PET/MRI for Brain Imaging 100 Peter Werner, Torsten Boehm, Solveig Tiepolt, Henryk Barthel, Karl T. Hoffmann and Osama Sabri Chapter 9 Brain Death 110 Marko Grmek Chapter 10 Health Care in Patients with Neurological Disorders 116 Claudiu Peștean Imprint 126 n accordance with the Austrian Eco-Label for printed matters.
    [Show full text]
  • Specific PET-Ligands for Selected 5-Htand GABA A-Receptor Subtypes
    Specific PET-ligands for Selected 5-HT and GABAA-Receptor Subtypes PET-Liganden mit Spezifität für definierte 5-HT und GABAA-Rezeptor-Subtypen Dissertation zur Erlangung des Grades „Doktor der Naturwissenschaften“ am Fachbereich Biologie der Fabian Debus geb. am 19.09.1976 in Frankfurt am Main Mainz, im März 2008 Erklärung Hiermit versichere ich, dass ich die vorliegende Dissertation eigenständig verfasst und keine anderen als die angegebenen Hilfsmittel verwendet habe. Die Dissertation habe ich weder als Arbeit für eine staatliche oder andere wissenschaftliche Prüfung eingereicht noch ist sie oder ein Teil dieser als Dissertation bei einer anderen Fakultät oder einem anderem Fachbereich eingereicht worden. Mainz, im März 2008 II Dekan: 1. Berichterstatter: 2. Berichterstatter: Tag der mündlichen Prüfung: 28.05.2008 III Danksagung Eine solche Schrift kann niemals als Ergebnis der Arbeit eines Einzelnen, sondern sollte immer als Resultat der Arbeit einer großen Anzahl von fleißigen Menschen betrachtet werden, die dabei mitgeholfen haben, dass aus einer Idee ein gelungenes Projekt wurde. Bei meinen beiden Betreuern, Prof. Dr. H. L. und Prof. Dr. F. R., möchte ich mich für das spannende und abwechslungsreiche Thema bedanken. Außerdem für Ihr Vertrauen und Ihre Diskussionsbereitschaft. Insbesondere Herrn Prof. Dr. H. L. möchte ich für seine Unterstützung und seine vorbildliche Betreuung danken. Ich hätte mir keinen besseren Doktorvater wünschen können und bin sehr dankbar für alles, was ich in diesen drei Jahren in seiner Arbeitsgruppe lernen durfte. Besonderer Dank gebührt der gesamten Arbeitsgruppe für Ihre herzliche Gemeinschaft und das produktive Miteinander. Im Einzelnen gebührt Frau R. Dank für das Licht im Dunkel der Bürokratie. Frau B.
    [Show full text]
  • Brain Metabolic Profile After Intranasal Vs. Intraperitoneal Clomipramine
    International Journal of Molecular Sciences Article Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression Olga Abramova 1,2, Yana Zorkina 1,2,* , Timur Syunyakov 2,3 , Eugene Zubkov 1, Valeria Ushakova 1,2, Artemiy Silantyev 1, Kristina Soloveva 2, Olga Gurina 1, Alexander Majouga 4, Anna Morozova 1,2 and Vladimir Chekhonin 1,5 1 V. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia; [email protected] (O.A.); [email protected] (E.Z.); [email protected] (V.U.); [email protected] (A.S.); [email protected] (O.G.); [email protected] (A.M.); [email protected] (V.C.) 2 Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia; [email protected] (T.S.); [email protected] (K.S.) 3 Federal State Budgetary Institution Research Zakusov Institute of Pharmacology, 125315 Moscow, Russia 4 Drug Delivery Systems Laboratory, D. Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia; [email protected] 5 Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia * Correspondence: [email protected]; Tel.: +7-916-588-4851 Citation: Abramova, O.; Zorkina, Y.; Abstract: Background: Molecular mechanisms of depression remain unclear. The brain metabolome Syunyakov, T.; Zubkov, E.; Ushakova, after antidepressant therapy is poorly understood and had not been performed for different routes V.; Silantyev, A.; Soloveva, K.; Gurina, of drug administration before the present study. Rats were exposed to chronic ultrasound stress O.; Majouga, A.; Morozova, A.; et al. and treated with intranasal and intraperitoneal clomipramine.
    [Show full text]
  • Astroglial Networks Scale Synaptic Activity and Plasticity
    Astroglial networks scale synaptic activity and plasticity Ulrike Pannascha, Lydia Vargováb,c, Jürgen Reingruberd, Pascal Ezana, David Holcmand, Christian Giaumea, Eva Sykováb,c, and Nathalie Rouacha,1 aCenter for Interdisciplinary Research in Biology, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7241/Institut National de la Santé et de la Recherche Médicale U1050, Collège de France, 75005 Paris, France; bDepartment of Neuroscience and Center for Cell therapy and Tissue Repair, Charles University, Second Faculty of Medicine, 150 06 Prague, Czech Republic; cDepartment of Neuroscience, Institute of Experimental Medicine of the Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic; and dInstitut de Biologie de l’Ecole Normale Supérieure, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8197/Institut National de la Santé et de la Recherche Médicale U1024, Department of Computational Biology and Mathematics, Ecole Normale Supérieure, Paris, 75005, France Edited* by Roger A. Nicoll, University of California, San Francisco, CA, and approved April 11, 2011 (received for review November 22, 2010) Astrocytes dynamically interact with neurons to regulate synaptic during synaptic activity. This impairment results in increased transmission. Although the gap junction proteins connexin 30 neuronal excitability, release probability, glutamate spillover, and (Cx30) and connexin 43 (Cx43) mediate the extensive network insertion of postsynaptic AMPARs, unsilencing synapses. Alto- organization of astrocytes, their role in synaptic physiology is un- gether, our findings indicate that gap junction-mediated astroglial known. Here we show, by inactivating Cx30 and Cx43 genes, that networks control synaptic strength by modulating extracellular astroglial networks tone down hippocampal synaptic transmission homeostasis.
    [Show full text]